Charley Grant

Industrials and health care for @wsjheard. Heralded by critics as "most lamentable.”

Categories
N/A
Content Types
N/A
More Information
Location|Languages
Publications

Published Content

343
Tax Credit for $35,000 Tesla Model 3 Slips Away
wsj.comArticle
Tax Credit for $35,000 Tesla Model 3 Slips Away
October, 12 2018
Biotech Is Down but Far From Out
wsj.comArticle
Biotech Is Down but Far From Out
October, 10 2018
The Future at Perrigo Is Brighter Than Investors Think
wsj.comArticle
The Future at Perrigo Is Brighter Than Investors Think
October, 9 2018
Surf’s Up, Wheels Up at United Airlines
wsj.comArticle
Surf’s Up, Wheels Up at United Airlines
October, 5 2018
バイオ医薬品会社の買収、干上がっている訳は
jp.wsj.comArticle
バイオ医薬品会社の買収、干上がっている訳は
October, 5 2018
Why Biotech Deal-Making Has Dried Up
wsj.comArticle
Why Biotech Deal-Making Has Dried Up
October, 4 2018
Something Happened at Pfizer?
wsj.comArticle
Something Happened at Pfizer?
October, 1 2018
テスラ出直し、新会長を待ち受ける仕事とは
jp.wsj.comArticle
テスラ出直し、新会長を待ち受ける仕事とは
October, 1 2018
Tesla Gets a Second Chance
wsj.comArticle
Tesla Gets a Second Chance
September, 30 2018
テスラ正念場、投資家が目覚めるのはまだ先か
jp.wsj.comArticle
テスラ正念場、投資家が目覚めるのはまだ先か
September, 28 2018
Truth and Consequences for Elon Musk and Tesla
wsj.comArticle
Truth and Consequences for Elon Musk and Tesla
September, 27 2018
Easy Come, Easy Go in Biotech
wsj.comArticle
Easy Come, Easy Go in Biotech
September, 27 2018
Some Good News From Rite Aid? It Is Possible
wsj.comArticle
Some Good News From Rite Aid? It Is Possible
September, 26 2018
Surprise Heart Data Is Just the Beginning for Amarin
wsj.comArticle
Surprise Heart Data Is Just the Beginning for Amarin
September, 24 2018
Teva Investors Get Headache Relief
wsj.comArticle
Teva Investors Get Headache Relief
September, 17 2018
The Worst Is Over for Generic-Drug Stocks
wsj.comArticle
The Worst Is Over for Generic-Drug Stocks
September, 14 2018
テスラの財務責任者、相次ぐ「脱走」の真相は
jp.wsj.comArticle
テスラの財務責任者、相次ぐ「脱走」の真相は
September, 8 2018
What Scared Off Tesla’s Accountant?
wsj.comArticle
What Scared Off Tesla’s Accountant?
September, 7 2018
テスラの運命変えたマスク氏の2つの決断
jp.wsj.comArticle
テスラの運命変えたマスク氏の2つの決断
August, 25 2018
How Two Musk Decisions in 2016 Put Tesla Into Trouble
wsj.comArticle
How Two Musk Decisions in 2016 Put Tesla Into Trouble
August, 24 2018
Abbott Labs Is a Rare Growth Story in Health Care
wsj.comArticle
Abbott Labs Is a Rare Growth Story in Health Care
August, 20 2018
テスラ、SECの調査で形勢一変 資金調達に壁
jp.wsj.comArticle
テスラ、SECの調査で形勢一変 資金調達に壁
August, 17 2018
The Game Has Changed at Tesla
wsj.comArticle
The Game Has Changed at Tesla
August, 17 2018
Why Mylan, Not Tesla, Is the Buyout to Bet On
wsj.comArticle
Why Mylan, Not Tesla, Is the Buyout to Bet On
August, 8 2018
テスラ非公開化の夢、残る数々の疑問
jp.wsj.comArticle
テスラ非公開化の夢、残る数々の疑問
August, 7 2018
Tesla’s Go-Private Dream Doesn’t Add Up
wsj.comArticle
Tesla’s Go-Private Dream Doesn’t Add Up
August, 7 2018
テスラの見通し、投資家好感も要注意
jp.wsj.comArticle
テスラの見通し、投資家好感も要注意
August, 2 2018
Tesla Profits: Be Careful What You Wish For
wsj.comArticle
Tesla Profits: Be Careful What You Wish For
August, 1 2018
MiMedx Gets Delisting Notice From Nasdaq
wsj.comArticle
MiMedx Gets Delisting Notice From Nasdaq
July, 26 2018
Caution Still Needed on Biogen Alzheimer’s Bounty
wsj.comArticle
Caution Still Needed on Biogen Alzheimer’s Bounty
July, 26 2018
テスラは「寄付」が命綱に、資金繰り探るマスク氏
jp.wsj.comArticle
テスラは「寄付」が命綱に、資金繰り探るマスク氏
July, 23 2018
Tesla Wants Its Money Back
wsj.comArticle
Tesla Wants Its Money Back
July, 23 2018
Biotech IPO Boom Comes With Side Effects
wsj.comArticle
Biotech IPO Boom Comes With Side Effects
July, 18 2018
株価を押し上げる「取り残される不安」
jp.wsj.comArticle
株価を押し上げる「取り残される不安」
July, 13 2018
Fear of Missing Out Drives Stock Performance
wsj.comArticle
Fear of Missing Out Drives Stock Performance
July, 13 2018
Drug Supply Chain Feels the Trump Effect
wsj.comArticle
Drug Supply Chain Feels the Trump Effect
July, 11 2018
Don’t Chase Biogen Into the Unknown on Alzheimer’s
wsj.comArticle
Don’t Chase Biogen Into the Unknown on Alzheimer’s
July, 6 2018
Why July Is a Risky Month for Drug Price Backlash
wsj.comArticle
Why July Is a Risky Month for Drug Price Backlash
July, 3 2018
テスラの生産目標達成、投資家は油断ならず
jp.wsj.comArticle
テスラの生産目標達成、投資家は油断ならず
July, 3 2018
Tesla’s Big Number Doesn’t Solve Its Problems
wsj.comArticle
Tesla’s Big Number Doesn’t Solve Its Problems
July, 2 2018
アマゾンの参入でドラッグストア業界に「悪寒」
jp.wsj.comArticle
アマゾンの参入でドラッグストア業界に「悪寒」
June, 28 2018
How Amazon Made Pharmacies Ill
wsj.comArticle
How Amazon Made Pharmacies Ill
June, 28 2018
テスラ「モデル3」の生産、悪い癖は直るのか
jp.wsj.comArticle
テスラ「モデル3」の生産、悪い癖は直るのか
June, 28 2018
Tesla’s Busy and Worrisome Week
wsj.comArticle
Tesla’s Busy and Worrisome Week
June, 27 2018
Sizing Up Tesla’s $10 Billion Debt Stack
wsj.comArticle
Sizing Up Tesla’s $10 Billion Debt Stack
June, 17 2018
Stryker Offer May Trigger Billions in Deal Making
wsj.comArticle
Stryker Offer May Trigger Billions in Deal Making
June, 11 2018
Allergan Needs a New Wrinkle
wsj.comArticle
Allergan Needs a New Wrinkle
June, 6 2018
バイオ企業ネクターの時価総額、1日で60億ドル吹き飛ぶ
jp.wsj.comArticle
バイオ企業ネクターの時価総額、1日で60億ドル吹き飛ぶ
June, 5 2018
In Biotech, $6 Billion Can Vanish Quickly
wsj.comArticle
In Biotech, $6 Billion Can Vanish Quickly
June, 4 2018
Tesla’s Numbers Are Even More Dramatic Than Its CEO
wsj.comArticle
Tesla’s Numbers Are Even More Dramatic Than Its CEO
May, 5 2018
Authorship Stats
2Sites343Projects32,184Words
About
Charley Grant is a writer who has produced content for wsj.com and jp.wsj.com
Key Phrases
Diversified Media, Leading Companies, Drug Prices, Wall Street, Elon Musk, Adjusted Earnings, Big Pharma, Health Care, Chief Executive, Drug Companies
© ClearVoice, Inc.